A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1997
11/19/1997	EP0807687A2 Herpesviral proteases, compositions capable of binding them and uses thereof.
11/19/1997	EP0807686A2 Interleukin-1 beta converting enzyme like apoptotic protease-7
11/19/1997	EP0807683A2 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/19/1997	EP0807121A1 New pharmaceuticals for modulating hormone responsiveness
11/19/1997	EP0806965A1 Cd44 expression in smooth muscle cells
11/19/1997	EP0806963A1 Carcinoma treatment
11/19/1997	EP0806960A1 Extracts of shark cartilage, process of production and uses thereof
11/19/1997	EP0806956A1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment and medicaments containing said nucleosides
11/19/1997	EP0806952A1 Progesterone antagonists useful for preparing medicaments for treating dysfunctional uterine bleeding
11/19/1997	EP0806951A1 Novel medical use of heme products
11/19/1997	EP0806947A1 Formulations and methods for reducing skin irritation
11/19/1997	CN1165483A Compositions of ciplatin in comination with 2,2'-dithio-bis (ethanesulfonate) (dinesna)
11/19/1997	CN1165000A Method of reducing tissue damage associated with ischemia
11/18/1997	US5688794 Administering metoclopramide
11/18/1997	US5688522 Ointment for wound treatment
11/18/1997	US5688499 Antagonism of endothelin actions
11/18/1997	US5688486 Use of fullerenes in diagnostic and/or therapeutic agents
11/18/1997	CA2116288C Ph-triggered osmotic bursting delivery devices
11/13/1997	WO1997042224A1 Neurotactin and uses therefor
11/13/1997	WO1997042222A1 Methods and means for inhibition of cdk4 activity
11/13/1997	WO1997041898A1 Targeted combination immunotherapy of cancer
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	WO1997041881A1 Morphogen treatment for chronic renal failure
11/13/1997	WO1997041880A1 Therapies for chronic renal failure
11/13/1997	WO1997041879A1 Enhancement of sleep with a growth hormone secretagogue
11/13/1997	WO1997041878A1 Treatment of mood disorders with a growth hormone secretagogue
11/13/1997	WO1997041875A1 Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
11/13/1997	WO1997041866A1 Improvement of implantation rates after in vitro fertilization
11/13/1997	WO1997041857A1 Composition comprising a katp channel inhibitor for use in the treatment of hemorrhagic shock
11/13/1997	WO1997041854A1 Inhibitors of glycogen synthase kinase-3 and methods for identifying and using the same
11/13/1997	WO1997041831A1 Stimulation of immune response with low doses of il-2
11/13/1997	WO1997041824A2 Antiangiogenic peptides derived from plasminogen
11/13/1997	WO1997037998A3 Neuropeptide y receptor y5 and nucleic acid sequence
11/13/1997	WO1997032607A3 Activated linkers and methods for making and purifying the same
11/13/1997	WO1997029195A3 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
11/13/1997	WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
11/13/1997	WO1996040048A3 Novel uses for thyroid hormones or thyroid hormone-like compounds
11/13/1997	DE19618797A1 Vehikel zum Transport molekularer Substanz Vehicle for the transport of molecular substance
11/13/1997	CA2253913A1 Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253904A1 Targeted combination immunotherapy of cancer
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253864A1 Neurotactin and uses therefor
11/13/1997	CA2253751A1 Improvement of implantation rates after in vitro fertilization
11/13/1997	CA2253390A1 Enhancement of sleep with a growth hormone secretagogue
11/13/1997	CA2251969A1 Composition comprising a katp channel inhibitor for use in the treatment of hemorrhagic shock
11/12/1997	EP0805859A1 A chemokine receptor able to bind to mcp-1, mip-1 alpha and/or rantes. its uses
11/12/1997	EP0805853A1 Lineage-directed induction of human mesenchymal stem cell differentiation
11/12/1997	EP0805683A1 5-carboxamido or 5-fluoro]- 2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
11/12/1997	EP0805678A1 Surface-modified nanoparticles and method of making and using same
11/12/1997	CN1164872A Novel compounds
11/12/1997	CN1164421A Preparation of drug for curing chronic fibrosis hepatic disease and acute hepatic disease using bradyknin-antagonist
11/11/1997	US5686489 Alpha hydroxyacid esters for skin aging
11/11/1997	US5686451 Combination of an ace inhibitor and a diuretic
11/11/1997	US5686436 Suppressing human immunodeficiency virus, feline immunodeficiency virus, feline leukemia virus
11/11/1997	US5686425 Composition and method for revitalizing scar tissue
11/11/1997	US5686414 Methods of treating conditions associated with corneal transplantation
11/11/1997	US5686292 Hepatocyte growth factor receptor antagonist antibodies and uses thereof
11/11/1997	US5686245 Methods for screening for agents which modulate telomere length
11/11/1997	US5686100 Prophylactic and therapeutic treatment of skin sensitization and irritation
11/06/1997	WO1997041443A2 Method for screening compounds
11/06/1997	WO1997041439A1 RECEPTOR FOR UNDERIVATIZED, AQUEOUS SOLUBLE β(1-3)-GLUCAN
11/06/1997	WO1997041263A1 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
11/06/1997	WO1997041252A2 Dna, rna and a protein useful for detection of a mycobacterial infection
11/06/1997	WO1997041222A1 HUMAN P2x4 RECEPTOR SPLICE-VARIANTS
11/06/1997	WO1997041211A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them
11/06/1997	WO1997041156A1 Novel compounds
11/06/1997	WO1997041151A2 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997	WO1997041147A1 Novel compounds
11/06/1997	WO1997041146A1 Novel compounds
11/06/1997	WO1997040857A1 Drug delivery using terminal complement components
11/06/1997	WO1997040851A1 Novel compounds
11/06/1997	WO1997040842A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/06/1997	WO1997040835A1 Treatment of carcinomas using squalamine in combination with other anti-cancer agents
11/06/1997	WO1997040832A1 Use of dipeptidyl peptidase iv effectors for lowering the blood glucose level in mammals
11/06/1997	WO1997040831A1 Therapeutic treatment for vegf related occular diseases
11/06/1997	WO1997040830A1 Therapeutic treatment for vegf related diseases
11/06/1997	WO1997040829A1 Growth inhibition and eradication of solid tumors using neuroendocrine resetting therapy and photodynamic therapy
11/06/1997	WO1997040813A1 Composition, barrier film, and method for preventing contact dermatitis
11/06/1997	WO1997040679A1 Methods for delivering compounds into a cell
11/06/1997	WO1997040670A1 Low ph acidic compositions
11/06/1997	WO1997033608A3 Antagonism of endothelin actions
11/06/1997	WO1997033566A3 Composition and dosage form comprising opioid antagonist
11/06/1997	CA2253608A1 Therapeutic treatment for vegf related diseases
11/06/1997	CA2253263A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/06/1997	CA2253252A1 Choline binding proteins for anti-pneumococcal vaccines
11/06/1997	CA2252617A1 Methods for delivering compounds into a cell
11/06/1997	CA2252542A1 Dna, rna and a protein useful for detection of a mycobacterial infection
11/06/1997	CA2252455A1 Molecules comprising an impdh-like binding pocket and encoded data storage medium capable of graphically displaying them
11/05/1997	EP0805203A1 The use of a substance which prevents HGS/SF from binding with Met
11/05/1997	EP0804615A1 Apolipoprotein e polymorphism and treatment of alzheimer's disease
11/05/1997	EP0804419A1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
11/05/1997	EP0804240A1 Compounds for preventing multidrug resistance in cancer cells containing protein kinase inhibitors
11/05/1997	EP0804239A1 Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
11/05/1997	EP0804238A1 Method to prevent transplant rejection
11/05/1997	EP0804229A2 Composition containing amlodipine, or a salt or felodipine and anace inhibitor
11/05/1997	EP0804196A1 Use of serotonin antagonists (5ht 3?) for treating fibromyalgia
11/05/1997	EP0804194A1 Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists
11/05/1997	EP0804191A1 Treatment of platelet derived growth factor related disorders such as cancers using inhibitors of platelet derived growth receptor

1 ... 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 1082 1083 1084 1085 ... 1151